Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Favennec, L.
Jave Ortiz, J.
Gargala, G.
Lopez Chegne, N.
Ayoub, A.
and
Rossignol, J. F.
2003.
Double‐blind, randomized, placebo‐controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru.
Alimentary Pharmacology & Therapeutics,
Vol. 17,
Issue. 2,
p.
265.
Wolstenholme, Adrian J.
Fairweather, Ian
Prichard, Roger
von Samson-Himmelstjerna, Georg
and
Sangster, Nicholas C.
2004.
Drug resistance in veterinary helminths.
Trends in Parasitology,
Vol. 20,
Issue. 10,
p.
469.
Walker, S. M.
McKinstry, B.
Boray, J. C.
Brennan, G. P.
Trudgett, A.
Hoey, E. M.
Fletcher, H.
and
Fairweather, I.
2004.
Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
Parasitology Research,
Vol. 94,
Issue. 6,
p.
427.
ALVAREZ, L. I.
MOTTIER, M. L.
and
LANUSSE, C. E.
2004.
Comparative assessment of the access of albendazole, fenbendazole and triclabendazole toFasciola hepatica: effect of bile in the incubation medium.
Parasitology,
Vol. 128,
Issue. 1,
p.
73.
Meaney, M.
Haughey, S.
Brennan, G. P.
and
Fairweather, I.
2005.
Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
Parasitology Research,
Vol. 95,
Issue. 3,
p.
201.
ALVAREZ, L. I.
SOLANA, H. D.
MOTTIER, M. L.
VIRKEL, G. L.
FAIRWEATHER, I.
and
LANUSSE, C. E.
2005.
Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes.
Parasitology,
Vol. 131,
Issue. 4,
p.
501.
Keiser, Jennifer
Engels, Dirk
Büscher, Gottfried
and
Utzinger, Jürg
2005.
Triclabendazole for the treatment of fascioliasis and paragonimiasis.
Expert Opinion on Investigational Drugs,
Vol. 14,
Issue. 12,
p.
1513.
Fairweather, I.
2005.
Triclabendazole: new skills to unravel an old(ish) enigma.
Journal of Helminthology,
Vol. 79,
Issue. 3,
p.
227.
Zhou, Hui
Tai, Yuanpo
Sun, Cuirong
and
Pan, Yuanjiang
2005.
Separation and characterization of synthetic impurities of triclabendazole by reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry.
Journal of Pharmaceutical and Biomedical Analysis,
Vol. 37,
Issue. 1,
p.
97.
McCONVILLE, M.
BRENNAN, G. P.
McCOY, M.
CASTILLO, R.
HERNANDEZ-CAMPOS, A.
IBARRA, F.
and
FAIRWEATHER, I.
2006.
Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
Parasitology,
Vol. 133,
Issue. 2,
p.
195.
Meaney, M.
Allister, J.
McKinstry, B.
McLaughlin, K.
Brennan, G. P.
Forbes, A. B.
and
Fairweather, I.
2006.
Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
Parasitology Research,
Vol. 99,
Issue. 5,
p.
609.
WALKER, S. M.
HOEY, E.
FLETCHER, H.
BRENNAN, G.
FAIRWEATHER, I.
and
TRUDGETT, A.
2006.
Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica.
Parasitology,
Vol. 133,
Issue. 2,
p.
209.
Mottier, L.
Alvarez, L.
Fairweather, I.
and
Lanusse, C.
2006.
RESISTANCE-INDUCED CHANGES IN TRICLABENDAZOLE TRANSPORT IN FASCIOLA HEPATICA: IVERMECTIN REVERSAL EFFECT.
Journal of Parasitology,
Vol. 92,
Issue. 6,
p.
1355.
Hegazi, Ahmed G.
Abd El Hady, Faten K.
and
Shalaby, Hatem A.
2007.
An in vitro effect of propolis on adult worms of Fasciola gigantica.
Veterinary Parasitology,
Vol. 144,
Issue. 3-4,
p.
279.
Meaney, M.
Allister, J.
McKinstry, B.
McLaughlin, K.
Brennan, G. P.
Forbes, A. B.
and
Fairweather, I.
2007.
Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
Parasitology Research,
Vol. 100,
Issue. 5,
p.
1091.
McKinstry, B.
Brennan, G. P.
Halferty, L.
Forbes, A. B.
and
Fairweather, I.
2007.
Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax).
Parasitology Research,
Vol. 101,
Issue. 4,
p.
929.
Brennan, G.P.
Fairweather, I.
Trudgett, A.
Hoey, E.
McCoy
McConville, M.
Meaney, M.
Robinson, M.
McFerran, N.
Ryan, L.
Lanusse, C.
Mottier, L.
Alvarez, L.
Solana, H.
Virkel, G.
and
Brophy, P.M.
2007.
Understanding triclabendazole resistance.
Experimental and Molecular Pathology,
Vol. 82,
Issue. 2,
p.
104.
McConville, M.
Brennan, G. P.
McCoy, M.
Castillo, R.
Hernandez-Campos, A.
Ibarra, F.
and
Fairweather, I.
2007.
Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
Parasitology Research,
Vol. 100,
Issue. 2,
p.
365.
Vara-Del Río, M. P.
Villa, H.
Martinez-Valladares, M.
and
Rojo-Vázquez, F. A.
2007.
Genetic heterogeneity of Fasciola hepatica isolates in the northwest of Spain.
Parasitology Research,
Vol. 101,
Issue. 4,
p.
1003.
Mestorino, N.
Formentini, E. A.
Lucas, M. F.
Fernandez, C.
Modamio, P.
Hernández, E. Mariño
and
Errecalde, J. O.
2008.
Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.
Veterinary Research Communications,
Vol. 32,
Issue. 1,
p.
21.